have diabetes and had Medicare as their primary payer during the study period, we
excluded 1421 patients who were not prescribed a CNI or sirolimus in combination or with
mycophenolate mofetil (MMF) or azathioprine (AZA), as described in the Concise Methods
section. The 20,124 study patients were less likely to be of white race than excluded patients
(68.5 versus 71.6% respectively; P= 0.04). Other demographic variables, including known …